Search results for " Outbreak"

showing 10 items of 640 documents

Development and validation of the Short Professional Quality of Life Scale based on versions IV and V of the Professional Quality of Life Scale

2020

Background This research presents a short version of the Professional Quality of Life (ProQOL) scale, one of the most frequently used questionnaires in the arena of applied healthcare investigation. It measures burnout (BO), compassion fatigue (CF), and compassion satisfaction (CS). Methods A 9-item version of the ProQOL was developed. In Study 1, this short version, which used items from version IV of the ProQOL, was administered to 817 palliative care professionals from Spain, Argentina, and Brazil. In Study 2, the same nine items, but this time from version V of the ProQOL, were administered to 296 Spanish palliative care professionals. Results Study 1: The Short ProQOL showed an adequat…

AdultCross-Cultural ComparisonMaleCoping (psychology)2019-20 coronavirus outbreakPalliative carecomparación transculturalAttitude of Health PersonnelhumanosArgentinaBurnoutlcsh:Computer applications to medicine. Medical informaticsQuality of life scale03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesHealth careHumans030212 general & internal medicineBurnout ProfessionalCompassion fatigue030504 nursingbusiness.industryResearchPalliative CarePublic Health Environmental and Occupational HealthValidation studyReproducibility of ResultsOccupational stressGeneral MedicineadultoHealth personnelactitud del personal sanitarioProfessional burnoutreproducibilidad de resultadoscuidados paliativosSpainCompassion fatiguecalidad de vidaQuality of Lifelcsh:R858-859.7FemaleOccupational stress0305 other medical sciencePsychologybusinessBrazilClinical psychologyHealth and Quality of Life Outcomes
researchProduct

Genomic analysis of the emergence and evolution of multidrug resistance during a Klebsiella pneumoniae outbreak including carbapenem and colistin res…

2014

et al.

AdultDNA BacterialMaleMicrobiology (medical)CarbapenemAntibiotic resistanceKlebsiella pneumoniaeMolecular Sequence DataNonsense mutationFosfomycinDisease OutbreaksMicrobiologyEvolution MolecularPlasmidAntibiotic resistanceMutation RateOutbreak genomicsmedicineHumansPharmacology (medical)AgedPharmacologyGeneticsbiologyColistinHypermutationSequence Analysis DNAMiddle Agedbiochemical phenomena metabolism and nutritionbiology.organism_classificationDrug Resistance MultipleAnti-Bacterial AgentsKlebsiella InfectionsMultiple drug resistanceKlebsiella pneumoniaeInfectious DiseasesCarbapenemsKlebsiella pneumoniae genomeColistinbacteriaFemaleGenome Bacterialmedicine.drugJournal of Antimicrobial Chemotherapy
researchProduct

Addressing the impact of SARS-CoV-2 infection in persons with congenital bleeding disorders: The Italian MECCOVID-19 study

2021

congenital bleeding disorders

AdultInheritedMalePediatricsmedicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)congenital bleeding disorderscongenital bleeding disorderSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)haemophiliaHemorrhageHaemophiliaLetter to the EditorsSARS‐CoV‐2Young AdultBlood Coagulation Disorders InheritedCOVID‐19congenital bleeding disorders; COVID-19; epidemiology; haemophilia; observational study; SARS-CoV-2; Adult; Aged; Blood Coagulation Disorders Inherited; COVID-19; Child Preschool; Disease Management; Female; Hemorrhage; Humans; Italy; Male; Middle Aged; SARS-CoV-2; Young AdultEpidemiologymedicineHumansYoung adultDisease management (health)ChildPreschoolLetter to the EditorGenetics (clinical)Agedbusiness.industrySARS-CoV-2COVID-19Disease ManagementHematologyGeneral MedicineBlood Coagulation DisordersMiddle Agedmedicine.diseaseItalySARS-CoV-2.Child PreschoolObservational studyepidemiologyobservational studyFemalebusiness
researchProduct

Epidemiological, clinical and genomic snapshot of the first 100 B.1.1.7 SARS-CoV-2 cases in Madrid

2021

A new SARS-CoV-2 variant, B.1.1.7, emerged in September in the UK, and is responsible for 76.6% of COVID-19 cases.1 This variant has also been reported in another 45 countries, 17 of them European.2,3 B.1.1.7 is considered to have higher transmissibility.4 It carries an unusually high number of specific mutations/deletions, 18, mostly non-synonymous and eight concentrate in the S gene,5 including several which might have relevant functional roles. The 69/70 deletion may be associated to immune response evasion6 and the N501Y substitution increases the affinity to the ACE2 receptor.7 These findings have raised the alarm of having to face a new variant with the potential to accelerate the spr…

AdultMale2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)AdolescentSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)030231 tropical medicine03 medical and health sciencesYoung Adult0302 clinical medicineResearch LetterMedicineHumans030212 general & internal medicineUKChildB.1.1.7travelAgedAged 80 and overTravelbusiness.industrySARS-CoV-2InfantCOVID-19General MedicineGenomicsMiddle AgedSpainChild PreschoolFemalebusinessHumanitiesAcademicSubjects/MED00295
researchProduct

Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy

2021

Therapies - Sous presse. Epreuves corrigees par l'auteur. Disponible en ligne depuis le mardi 13 avril 2021

AdultMale2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)COVID-19 vaccines030226 pharmacology & pharmacyArticle03 medical and health sciencesPharmacovigilance0302 clinical medicineBell's palsyPhase 3 clinical trialsBell PalsymedicineType I interferonsHumansBell's palsyPharmacology (medical)Potential mechanismComputingMilieux_MISCELLANEOUSAgedCOVID-19 coronavirus disease 2019Vaccines SyntheticMessenger RNASARS-CoV-2business.industryCOVID-19Bell’s palsyMiddle Agedmedicine.diseaseVirologymRNA messenger RNA3. Good healthInterferon Type IFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusiness
researchProduct

Changes in Alcohol Consumption Pattern Based on Gender during COVID-19 Confinement in Spain

2021

(1) The goal of this study was to analyze the prevalence and pattern of alcohol consumption (frequency of consumption, average daily consumption, and risky consumption) before and during confinement due to the coronavirus disease (COVID-19) in the adult population and based on gender. (2) Methods: Data from 3779 individuals were collected via a set of online surveys. The AUDIT alcohol consumption questions (AUDIT-C) were used to measure the frequency of consumption, the average daily consumption, intensive consumption, risky consumption, and standard drink units. (3) Results: During confinement, the prevalence of alcohol consumption declined in both males and females, but only intensive con…

AdultMale2019-20 coronavirus outbreakmedicine.medical_specialty6114.06 Comportamiento del ConsumidorCoronavirus disease 2019 (COVID-19)Alcohol DrinkingHealth Toxicology and Mutagenesis3309.01 Bebidas Alcohólicasrisk consumptionHealth BehaviorAdult populationFrequency of use030508 substance abusestandard drink unit (SDU)Article03 medical and health sciences0302 clinical medicine6302.02 Psicología SocialSurveys and QuestionnairesgenderMedicineHumans030212 general & internal medicineConsumption (economics)business.industryalcoholSARS-CoV-2Public healthPublic Health Environmental and Occupational HealthRCOVID-19confinement measures63 SociologíaStandard drinkSpainMedicineFemale0305 other medical sciencebusinessAlcohol consumptionDemographyInternational Journal of Environmental Research and Public Health
researchProduct

Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis

2021

AdultMale2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)prospective cohortMEDLINEDermatologyregistryimmunosuppressive agentsSeverity of Illness IndexCOVID-19 (Malaltia)ArticleCohort StudiesInternal medicinePandemicPsoriasisHumansMedicinebiologic therapyRegistriesAgedbusiness.industryIncidenceIncidence (epidemiology)COVID-19COVID-19 Psoriasis biologic therapy immunosuppressive agents pharmacovigilance prospective cohort registryMiddle AgedSpainpharmacovigilanceFemalebusinessPsoriasi -- TractamentCohort studyJournal of the American Academy of Dermatology
researchProduct

Challenges of patients with myeloproliferative neoplasms (MPN) in times of COVID: first results from a patient survey by the German Study Group for M…

2021

AdultMaleCancer Researchmedicine.medical_specialty2019-20 coronavirus outbreakAdolescentCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINEGermanYoung AdultGermanySurveys and QuestionnairesInternal medicineCorrespondencemedicineHumansAgedAged 80 and overMyeloproliferative DisordersSARS-CoV-2business.industryCOVID-19HematologyMiddle AgedPrognosisTelemedicinelanguage.human_languageOncologylanguageFemalePatient surveybusinessFollow-Up StudiesLeukemia Research
researchProduct

[Investigation of an outbreak of norovirus gastroenteritis in a geriatric hospital]

2005

National audience; In aged-care facilities, gastroenteritis outbreaks are responsible for big trouble in the management of cares to the elderly. In November 2002, a gastroenteritis outbreak was observed in 5 of the 6 wards of the geriatric hospital La Charité, University Hospital of Saint-Etienne, France, with an attack rate of 38.5% in the elderly (70 infected from 182 patients) and of 26.0% in the nursing staff (40 infected from 154 agents). The outbreak lasted 30 days with a peak corresponding to 79.8% of the cases between the 11(th) and the 20(th) of November. The first cases were observed in the two short-term-care wards; then, the outbreak spread rapidly to 3 of the 4 long-term care u…

AdultMaleMESH: NorovirusMESH : MaleMESH : Hospitals SpecialMESH : AgedMESH: GeriatricsHospitals Special[ SDV.MP.VIR ] Life Sciences [q-bio]/Microbiology and Parasitology/VirologyDisease OutbreaksMESH: Aged 80 and overHumansMESH : Middle AgedMESH : Disease OutbreaksMESH : FemaleMESH: Disease OutbreaksMESH : Aged 80 and overMESH : GeriatricsMESH: Caliciviridae InfectionsAgedCaliciviridae InfectionsAged 80 and overMESH: Aged[SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/VirologyMESH: Middle AgedMESH: HumansMESH : NorovirusNorovirusMESH : HumansMESH: Hospitals SpecialMESH: AdultMiddle AgedMESH : AdultMESH: MaleMESH: GastroenteritisGastroenteritisMESH : GastroenteritisGeriatrics[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyFemaleMESH : Caliciviridae InfectionsMESH: Female
researchProduct

Diagnostic significance of SARS-CoV-2 IgM positive/IgG negative antibody profile in symptomatic patients with suspected COVID-19 testing negative by …

2020

An outbreak of new coronavirus SARS-CoV-2 was occurred in Wuhan, China and rapidly spread to other cities and nations. The standard diagnostic approach that widely adopted in the clinic is nucleic acid detection by real-time RT-PCR. However, the false-negative rate of the technique is unneglectable and serological methods are urgently warranted. Here, we presented the colloidal gold-based immunochromatographic (ICG) strip targeting viral IgM or IgG antibody and compared it with real-time RT-PCR. The sensitivity of ICG assay with IgM and IgG combinatorial detection in nucleic acid confirmed cases were 11.1%, 92.9% and 96.8% at the early stage (1-7 days after onset), intermediate stage (8-14 …

AdultMaleMicrobiology (medical)2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralNegative antibodyReal-Time Polymerase Chain ReactionAntibodies ViralArticleImmunoglobulin GBetacoronavirusYoung AdultCOVID-19 TestingHumansMedicineSerologic Testsskin and connective tissue diseasesPandemicsAgedAged 80 and overImmunoassaybiologyReverse Transcriptase Polymerase Chain ReactionSARS-CoV-2business.industryfungiCOVID-19Middle AgedVirologybody regionsInfectious DiseasesReal-time polymerase chain reactionImmunoglobulin MImmunoglobulin MImmunoglobulin Gbiology.proteinFemaleAntibodyCoronavirus InfectionsbusinessJournal of Infection
researchProduct